AVAV: Earnings Loom as Drone Stock Falls 45%
Key Takeaways
- AVAV trades at $229.80, down 45% from its 52-week high, with Q3 earnings due March 10.
- Revenue has nearly tripled to $472.5M quarterly, but gross margins collapsed from 38% to 17% after the BlueHalo acquisition.
- The $1.4B SCAR Space Force contract, reopened for competitive bidding, is the single biggest swing factor for the stock.
- Analysts expect EPS to turn positive by FY2028, with quarterly estimates ranging from $1.10 to $2.05.
AeroVironment (AVAV) reports Q3 FY2026 earnings on March 10 with the stock trading at $229.80 — down 45% from its 52-week high of $417.86. The defense drone maker has been one of the most volatile names in the aerospace sector, with a 134% surge in funded backlog colliding with margin compression from its BlueHalo acquisition.
The setup heading into Monday's report is unusually binary. Bulls point to revenue that has nearly tripled year-over-year and a geopolitical environment tailor-made for AeroVironment's Switchblade loitering munitions. Bears counter that gross margins have been cut in half, the stock is trading at nearly 40x sales, and a pivotal $1.4B Space Force contract hangs in competitive limbo.
With the stock down 11.5% in the past week alone and a Pomerantz law firm investigation adding noise, investors need to parse what's real and what's priced in before the bell rings Monday evening.
Valuation: Premium Multiple on Negative Earnings
AeroVironment's valuation is difficult to assess through traditional metrics. The company is currently unprofitable on a trailing twelve-month basis, with EPS of -$1.21, rendering the PE ratio meaningless. The stock trades at 4.2x book value ($88.85 per share) and roughly 39x trailing sales — both elevated for a defense contractor.
The enterprise value of approximately $18.9 billion against quarterly EBITDA of $37.5 million (Q2 FY2026) implies an annualized EV/EBITDA north of 125x. Even using the more profitable Q4 FY2025 quarter ($50.3M EBITDA) as a baseline, the multiple remains above 90x.
AVAV Valuation Multiples by Quarter
These multiples reflect a market betting heavily on future revenue ramp rather than current profitability. The question is whether Q3 earnings can demonstrate a path back to the high-30s gross margins management has guided toward.
Revenue Surge: BlueHalo Integration Drives Top Line
Revenue growth has been extraordinary. Q2 FY2026 revenue hit $472.5 million, up from $167.6 million in Q3 FY2025 — a 182% increase driven primarily by the BlueHalo acquisition. Sequential growth has been more modest, with Q2 up 3.9% from Q1's $454.7 million.
AVAV Quarterly Revenue ($M)
The top-line story is compelling, but it masks a crucial detail: profitability has deteriorated sharply. Q2 gross margin fell to 17.4%, down from 38.0% in Q4 FY2025. Operating income swung to a loss of $22.0 million. The BlueHalo integration has diluted margins significantly, though management expects recovery to the high-30s by Q4 FY2026.
Net income was -$17.1 million in Q2 and -$67.4 million in Q1, reflecting integration costs and the lower-margin revenue mix from BlueHalo's space and cyber segments.
Financial Health: Strong Liquidity, Manageable Debt
Despite the earnings losses, AeroVironment's balance sheet remains solid. The current ratio stands at 5.08, indicating ample short-term liquidity. The debt-to-equity ratio of 0.19 is conservative for a company that just completed a major acquisition.
Free cash flow has been negative at -$0.45 per share in Q2, an improvement from -$3.12 in Q1. The cash conversion cycle of 179 days reflects the long-cycle nature of defense contracts. The quick ratio of 4.29 and cash ratio of 1.10 provide additional cushion.
The funded backlog of $1.1 billion, up 134% year-over-year, provides substantial revenue visibility. However, free cash flow generation needs to turn positive to justify the current market capitalization of $11.5 billion.
Defense Tailwinds and the SCAR Contract Risk
AeroVironment sits at the intersection of two powerful defense trends: autonomous systems and the proven battlefield effectiveness of loitering munitions. The Switchblade family of drones has been validated in combat, creating a demand pull that extends well beyond Ukraine.
U.S.-Iran tensions have further elevated the company's profile. As MarketBeat noted this week, geopolitical instability is acting as a "powerful catalyst for the defense industry," and AeroVironment's drone platforms are among the most combat-proven systems available.
The critical risk is the $1.4 billion SCAR contract (Space Force). This contract was reopened for competitive bidding — winning it would roughly double the current funded backlog, while losing it would remove a significant growth assumption embedded in the stock price. Seeking Alpha analysts have flagged this as the key variable heading into earnings.
The Pomerantz law firm investigation announced March 5 adds legal uncertainty, though such investigations are common for stocks with significant price declines and don't necessarily indicate wrongdoing.
Forward Outlook: Margin Recovery Is the Catalyst
Analyst estimates project substantial revenue growth continuing through FY2027 and FY2028. Consensus estimates show quarterly revenue reaching $590.7 million by Q1 FY2028 and $830.9 million by Q4 FY2028, implying annual revenue approaching $2.7 billion.
EPS is expected to turn decisively positive, with estimates ranging from $1.10 to $2.05 per quarter through FY2028. This would represent a dramatic recovery from the current -$1.21 TTM figure.
AVAV Forward EPS Estimates
Monday's Q3 report will be watched primarily for gross margin trajectory. Management has guided for a return to the "high 30s" by Q4, driven by higher-margin product revenues overtaking lower-margin integration work. If Q3 shows meaningful progress toward that target — say, gross margins in the mid-to-high 20s — the stock could rally sharply. Conversely, continued margin pressure near 17-20% would validate the bears' thesis that BlueHalo integration costs are structural rather than temporary.
Conclusion
AeroVironment presents a classic high-risk, high-reward setup ahead of Monday's earnings. The company is riding genuine defense tailwinds with a tripled revenue base and record backlog, but profitability has evaporated in the near term and the valuation assumes a margin recovery that hasn't materialized yet.
The stock is most appropriate for investors with high risk tolerance who believe in the structural defense spending thesis and management's margin recovery timeline. At $229.80, the stock has already priced in considerable pessimism — down 45% from highs — but further downside is possible if Q3 margins disappoint or the SCAR contract is lost. Conservative investors should wait for evidence of margin inflection before committing capital.
Frequently Asked Questions
Sources & References
www.marketbeat.com
seekingalpha.com
Disclaimer: This content is AI-generated for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.